Results 71 to 80 of about 17,237 (205)
Anticardiolipin antibodies and coronary heart disease [PDF]
, 2017 Arterial or venous thrombotic events have been described as complications in patients with positive anticardiolipin antibodies (aCL), affecting various organs including the heart.
BURKART, F. +3 more
core
Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data [PDF]
, 2014 Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO).
Kolář Petr
core +4 more sources
Clinical Case Reports, Volume 13, Issue 12, December 2025.Atypical manifestation of primary antiphospholipid syndrome: Celiac trunk thrombosis. ABSTRACT Aortic and celiac trunk thrombosis is an exceptional manifestation of antiphospholipid syndrome (APS). A 36‐year‐old woman with triple‐positive APS, prior ischemic strokes, and chronic hypertension discontinued her anticoagulation therapy with acenocoumarin 1
Alejandra Albarrán‐Sánchez +7 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 12, December 2025.ABSTRACT Severe autoimmune thrombocytopenia (ATP) in systemic lupus erythematosus (SLE) patients can be life‐threatening when refractory to standard treatments. Low‐dose splenic irradiation (LDSI) can provide temporary platelet recovery before definitive splenectomy.
Ryosuke Hanaoka
wiley +1 more source
Kidney disease in primary anti-phospholipid antibody syndrome [PDF]
, 2017 APS is an autoimmune disease defined by the presence of arterial or venous thrombotic events and/or pregnancy morbidity in patients who test positive for aPL. APS can be isolated (primary APS) or associated with other autoimmune diseases. The kidney is a
Gracia-Tello, B, Isenberg, D
core
Health Science Reports, Volume 8, Issue 12, December 2025.ABSTRACT Background and Aims Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, and recent findings reveal that fertility and ovarian reserve are reduced even in moderate illness, showing that SLE has a direct impact on ovarian function.
Shaghayegh Moradi Alamdarloo +6 more
wiley +1 more source
Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus. [PDF]
, 1992 The antiphospholipid syndrome was initially described in 1986. To reassess the validity of antiphospholipid antibodies in systemic lupus erythematosus (SLE), 95 patients with SLE were studied.
Cervera i Segura, Ricard, 1960- +5 more
core +1 more source
Evaluation of Antiphospholipid Antibodies and Activated Partial Thromboplastin Time in Women with Adverse Outcome of Pregnancy [PDF]
Iranian Journal of Medical Sciences, 2010 Adverse outcome of pregnancy is a potentially dangerouscomplication of conception and affects 15-20% of pregnancies.According to recent studies increased level of bloodantiphospholipids antibodies, if accompanied by predisposingfactors, can be an adverse
Sariyeh Golmahammad lou +4 more
doaj
Antiphospholipid Syndrome Antibodies — Snippets from the Laboratory
Proceedings of Singapore Healthcare, 2013 Antiphospholipid (aPL) antibodies refer to antibodies associated with the clinical syndrome of vascular thrombosis and/or pregnancy morbidity, termed as aPL syndrome (APS).
Justin Hung Tiong Tan MBBS, MRCPCH (UK) +2 more
doaj +1 more source